Dexcom (NSDQ:DXCM) topped sales and earnings expectations on Wall Street today with its second-quarter financial results.
The San Diego, Calif.-based company posted profits of $30.2 million, or 34¢ per share, on sales of $242.5 million for the three months ended June 30, representing a whopping 941% increase in profits and a 42% increase in sales compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.